Posts

Mapping Human and Mouse Fat Tissue at Single-Cell Level

In a groundbreaking advancement that promises to reshape our understanding of me...

Recyclable Polyolefin-Like Materials with Weakened Back...

In the ever-evolving landscape of polymer chemistry, the quest for sustainable a...

Gut Microbiome’s Role in Cancer and Therapy

The intricate relationship between the gut microbiome and cancer has emerged as ...

Chemical Ventures: From Ideas to Scaled Solutions

In recent years, the journey from conceptual chemical innovations to fully scale...

Incretin-Based Therapies Combat Neurodegenerative Diseases

Neurodegenerative disorders have long posed one of the most daunting challenges ...

Advancing Microbiome Research via Next-Gen Anaerobic Cu...

In recent years, the study of microbiomes has revolutionized our understanding o...

Unlocking Small-Molecule Mass Spectrometry with Self-Su...

In the rapidly evolving landscape of analytical chemistry and bioinformatics, th...

Tumor-Microenvironment Crosstalk Drives NSCLC Progressi...

The landscape of non-small-cell lung cancer (NSCLC) treatment is transforming at...

EU Green Deal Falls Short of Food System Breakthrough

The European Union’s ambitious agenda to transform its agricultural and food sys...

GLP-1R Agonists Rewire Energy to Combat Alzheimer’s

In a groundbreaking study poised to transform our understanding of neurodegenera...

Gut Microbiota’s Role in Immune Side Effects

Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of on...

Stop Skin Aging This Summer With Zinc: Here’s How

There’s nothing like soaking up the summer sun. But your skin might not be enjoy...

EC approves BMS’ nivolumab SC formulation for solid tum...

The EC has granted approval for the new subcutaneous (SC) formulation of Bristol...

ASCO25: Merck KGaA to seek approval of TGCT drug after ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met...

Scynexis resumes dosing in Phase III MARIO study after ...

Scynexis has resumed dosing of its Brexafemme (ibrexafungerp) drug in a Phase II...

Daiichi Sankyo and MSD withdraw US application for lung...

Daiichi and MSD have voluntarily withdrawn the BLA in the US for their patrituma...